The pharmaceutical industry and biotechnology are creating innovative treatments and drugs to improve people's health and increase life expectancy.
In the interest of patient safety, this industry is highly regulated. Compliance with standards, quality assurance and traceability play a crucial role here. In manufacturing, process control is critical.
The sector also has to deal with pressure from environmental authorities. In addition, competitive advantage often depends on speed, which means that pharmaceutical companies are under constant pressure to innovate as quickly as possible.
Overall, however, price pressures reduce the number of new pharmacological products entering the market. This effect is amplified by the fact that companies have to renew patents on the brand name of medicines.